Randomized Non-inferiority Trial Comparing the Nevirapine-based Antiretroviral Therapy Versus the Standard Efavirenz-based ART for the Treatment of HIV-TB Co-infected Patients on Rifampicin-based Therapy (ANRS 12146 CARINEMO).
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Nevirapine (Primary) ; Efavirenz; Lamivudine/stavudine; Rifampicin
- Indications HIV infections; Tuberculosis
- Focus Adverse reactions; Therapeutic Use
- Acronyms CARINEMO
- 06 Mar 2014 Results presented at the 21st Conference on Retroviruses and Opportunistic Infections.
- 15 Feb 2012 Biomarkers information updated
- 17 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.